Just like the 2020 resolution, Novartis AG’s $25 million 2016 civil resolution Along with the SEC anxious inappropriate sponsorships of HCPs to conferences and incorrect payments to HCPs to gather “medical data.” The fact that Novartis is currently experiencing a considerably bigge